KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED

Scale -

Revenue is 3905 Rs Cr; Annual Growth is 29 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 24 %
Ebitda is 828 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 11 %
Quarterly Revenue is 1180 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile
Quarterly Ebitda is 223 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile

PBT is 55.6 Rs Cr; Annual Decline is -39 %
PAT is 239 Rs Cr; Annual Decline is -41 %

Profitability -

PBDIT Margin is 21.21 %; Annual Decline is -21 %; 5 Year CAGR is -10 %
PAT Margin is 6.13 %; Annual Decline is -54 %; Continuous Decline over 3 years; 5 Year CAGR is -26 %
Quarterly Ebitda Margin is 19 %; Continuous Decline over 3 Quarters
Quarterly Profit margin is 3 %; in Bottom Quartile

Return -

ROCE is 8.35 %; Annual Decline is -36 %; Continuous Decline over 3 years; 5 Year CAGR is -26 %
ROA is 3.11 %; Annual Decline is -54 %; Continuous Decline over 3 years; 5 Year CAGR is -35 %
ROE is 10.74 %; Annual Decline is -40 %; 5 Year CAGR is -18 %
Asset Turnover is 58 %; Continuous Decline over 3 years

Efficiency -

Operating cash flow is 511 Rs Cr; in Top Quartile

Current Ratio is 0.76; Continuous Decline over 3 years; in Bottom Quartile
Quick Ratio is 0.68; Continuous Decline over 3 years; in Bottom Quartile

Solvancy -

Debt/Equity is 1.44; Annual Growth is 62 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 86 %
Long term Debt is 2673 Rs Cr; Annual Growth is 62 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 110 %
Total Debt is 3244 Rs Cr; Annual Growth is 70 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 112 %
Contingent Liabilities is 1231 Rs Cr; in Top Quartile; 5 Year CAGR is 86 %

Quality -

Operating cashflow/PAT is 213 %; Annual Growth is 48 %; 5 Year CAGR is 22 %
Change in Inventories/Total Expenses is -1 %; Annual Decline is -71 %; Continuous Decline over 3 years; in Bottom Quartile
Exceptional Items/PBT is -3 %; in Bottom Quartile

Current Tax/PAT is 57 %; Annual Growth is 54 %; Continuous Growth over 3 years; in Top Quartile
Operating cashflow/ebitda is 62 %; Continuous Decline over 3 years
Other Expenses/Total Expenses is 45 %; Continuous Growth over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: